WMK · Weis Markets, Inc.

Weis Markets delivered strong Q1 2026 results with total revenue reaching $1.26 billion, a 4.6% increase from $1.20 billion in the prior year, driven by net sales growth to $1.252 billion. Comparable store sales excluding fuel rose 1.2% year-over-year and 2.2% on a two-year stacked basis, reflecting effective promotional and loyalty programs amid investments in facilities and technology. Gross profit expanded to $330.2 million from $298.2 million, while operating expenses increased to $294.5 million from $276.5 million, yielding operating income of $35.7 million versus $21.8 million last year. Net income surged 42.5% to $27.85 million, with EPS at $1.13 compared to $0.73, supported by lower weighted-average shares outstanding. Pharmacy revenue faced a $7.48 million headwind from Inflation Reduction Act Medicare pricing on ten drugs effective January 2026. CEO Jonathan H. Weis highlighted investments lowering costs and enhancing customer experience, including 2025's 17 large projects like five new stores and over 1,000 smaller upgrades. The board declared a $0.34 quarterly dividend, payable May 26, 2026, signaling confidence in cash generation. No forward guidance was provided, but management emphasized ongoing capital expenditures for efficiency and growth.